Market By Type, Substrate Material, End Users And Geography | Forecasts 2019-2027
The Europe biochips market is expected to display an upward trend and is estimated to grow at a CAGR of 18.91% during the forecasted years of 2019 to 2027.
The countries covered in the Europe biochips market are:
o United Kingdom
o Germany
o France
o Italy
o Spain
o Russia
o Rest of Europe
We provide additional customization based on your specific requirements. Request For Customization
Biochips finds its uses in areas like genomics (for cancer diagnosis and treatment), drug discovery, gene expression, point of care & In Vitro diagnosis and proteomics. Germany & the UK are the most significant economies in the European region for biochips market. Germany holds the largest share in the European biochips market. The biochips market is studied based on various segments, which include type, substrate material, and end users.
The report of the biochips market by Triton provides the market insights of DNA chips, protein chips, and lab on chip substrate materials. The report also provides details about Porter’s five force analysis, market definition, market attractiveness index, vendor scorecard, regulatory framework, forecast, and market sizing of biochips market in the European region, followed by the market drivers, restraints, opportunities and challenges.
The increasing application of biochips in biotechnology and biomedical fields is rapidly driving the demand of the biochips market in the European region. The major driving factor for biochips market in Europe is the increasing adoption of biochips in microarrays and proteomics. The availability of alternative technologies is the key restraint hampering the biochips market growth in the region.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. BIOCHIPS
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.3. EVOLUTION
& TRANSITION OF BIOCHIPS
2.4. PORTER'S
FIVE FORCE ANALYSIS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
IMPACT ANALYSIS
2.10.
MARKET OPPORTUNITY INSIGHTS
2.11.
INDUSTRY PLAYER POSITIONING
2.12.
KEY MARKET STRATEGIES
2.13.
MARKET DRIVERS
2.13.1.
GROWTH IN PERSONALIZED
MEDICINES
2.13.2.
RISING INCIDENCES &
TREATMENT OF CANCER
2.13.3.
CONSTANT RISE IN HEALTHCARE
SPENDING WORLDWIDE
2.13.4.
INCREASING NUMBER OF
INVESTMENTS IN BIOTECHNOLOGY R&D
2.14.
MARKET RESTRAINTS
2.14.1.
INEQUALITY IN HEALTHCARE
ACCESS
2.14.2.
INADEQUATE TECHNICAL AWARENESS
RELATED TO BIOCHIPS
2.14.3.
COMPLEXITY OF BIOLOGICAL
SYSTEMS
2.15.
MARKET OPPORTUNITIES
2.15.1.
DEVELOPMENTS IN BIOCHIPS
TECHNOLOGY
2.15.2.
WIDENING APPLICATION AREAS OF
BIOCHIPS
2.16.
MARKET CHALLENGES
2.16.1.
AVAILABILITY OF SUBSTITUTE
TECHNOLOGIES
2.16.2.
UNCLEAR REGULATORY GUIDELINES
2.16.3.
COST CONSTRAINTS
3. BIOCHIPS
INDUSTRY OUTLOOK – BY TYPE
3.1. DNA
CHIPS
3.1.1. AGRICULTURAL
BIOTECHNOLOGY
3.1.2. CANCER
DIAGNOSTICS & TREATMENT
3.1.3. DRUG
DISCOVERY
3.1.4. GENE
EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE
NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER
DNA CHIPS
3.2. LAB
ON A CHIP
3.2.1. CLINICAL
DIAGNOSTICS
3.2.2. DRUG
DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT
OF CARE & IN VITRO DIAGNOSIS
3.2.5. PROTEOMICS
3.2.6. OTHER
LAB ON A CHIP
3.3. PROTEIN
CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG
DISCOVERY
3.3.3. EXPRESSION
PROFILING
3.3.4. HIGH
THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER
PROTEIN CHIPS
3.4. OTHER
CHIPS
3.4.1. CELL
ARRAYS
3.4.2. TISSUE
ARRAYS
4. BIOCHIPS
INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER
SUBSTRATE MATERIALS
5. BIOCHIPS
INDUSTRY OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY
AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS
AND DIAGNOSTICS CENTERS
5.3. ACADEMIC
AND RESEARCH INSTITUTE
6. BIOCHIPS
INDUSTRY - EUROPE
6.1. UNITED
KINGDOM
6.2. GERMANY
6.3. FRANCE
6.4. ITALY
6.5. SPAIN
6.6. RUSSIA
6.7. REST
OF EUROPE
7. COMPETITIVE
LANDSCAPE
7.1. AGILENT
TECHNOLOGY INC.
7.2. BIOCHAIN
INSTITUTE INC.
7.3. BIOMERIEUX
SA
7.4. BIO-RAD
LABORATORIES INC.
7.5. CEPHEID
INC.
7.6. CYBRDI
INC.
7.7. FLUIDIGM
CORPORATION
7.8. GAMIDA
FOR LIFE GROUP
7.9. ILLUMINA
INC.
7.10.
IMGENEX
7.11.
MERCK GMBH
7.12.
ORIGENE TECHNOLOGIES INC.
7.13.
PERKINELMER INC.
7.14.
SAMSUNG ELECTRONICS INC.
7.15.
THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1. MARKET
ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET
TABLE 2. VENDOR SCORECARD
OF BIOCHIPS MARKET
TABLE 3. REGULATORY
FRAMEWORK OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC
DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. NOTABLE
INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
TABLE 6. EUROPE
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 7. EUROPE
BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 8. EUROPE
BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 9. EUROPE
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
FIGURE 1. EUROPE
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 2. PORTER’S FIVE
FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT
ANALYSIS
FIGURE 4. TIMELINE OF
BIOCHIPS
FIGURE 5. MARKET
OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 6. MARKET OPPORTUNITY
INSIGHTS, BY END USER, 2018
FIGURE 7. INDUSTRY
COMPONENTS OF BIOCHIPS MARKET
FIGURE 8. KEY PLAYER
POSITIONING IN 2018 (%)
FIGURE 9. COMPARISON OF
HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE
FIGURE 10. EUROPE BIOCHIPS
MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 11. EUROPE DNA
CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
FIGURE 12. EUROPE DNA
CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
FIGURE 13. EUROPE DNA
CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 14. EUROPE DNA
CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
FIGURE 15. EUROPE DNA
CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 16. EUROPE DNA
CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN
$ MILLION)
FIGURE 17. EUROPE DNA
CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 18. EUROPE
BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 19. EUROPE LAB
ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 20. EUROPE LAB
ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 21. EUROPE LAB
ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 22. EUROPE LAB ON
A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $
MILLION)
FIGURE 23. EUROPE LAB
ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 24. EUROPE LAB
ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 25. EUROPE
BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 26. EUROPE
PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 27. EUROPE
PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 28. EUROPE
PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 29. EUROPE
PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
FIGURE 30. EUROPE
PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 31. EUROPE
PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 32. EUROPE
BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 33. EUROPE OTHER
BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 34. EUROPE OTHER
BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 35. EUROPE
BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
FIGURE 36. EUROPE
BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 37. EUROPE
BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 38. EUROPE
BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
FIGURE 39. EUROPE
BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $
MILLIONS)
FIGURE 40. EUROPE
BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $
MILLIONS)
FIGURE 41. EUROPE
BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
FIGURE 42. EUROPE
BIOCHIPS MARKET, REGIONAL OUTLOOK, 2017 & 2026 (IN %)
FIGURE 43. UNITED
KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 44. GERMANY
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 45. FRANCE
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 46. ITALY
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 47. SPAIN BIOCHIPS
MARKET, 2019-2027 (IN $ MILLION)
FIGURE 48. RUSSIA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 49. REST OF
EUROPE BIOCHIPS MARKET, (IN $ MILLION)